SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dettagli Bibliografici
Autore principale:	Meem, Manila
Altri autori:	Akter, Dr. Raushanara
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2023
Soggetti:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Accesso online:	http://hdl.handle.net/10361/18081

Documenti analoghi

A review on potential of PARP inhibitors in the treatment of prostate cancer
di: Islam, Saidul
Pubblicazione: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
di: Ratu, Tabassum
Pubblicazione: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

Identification of FAP inhibitors using in silico simulation study
di: Deeba, Maliha Tasnim
Pubblicazione: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
di: Oshin, Sadia Afrin
Pubblicazione: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
di: Karim, Azrin
Pubblicazione: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
di: Mirza, Maisa Tasnim
Pubblicazione: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
di: Khan, Muidul Hasan
Pubblicazione: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
di: Islam, Nahidul
Pubblicazione: (2023)

A review on targeted therapies for lung cancer
di: Ashraf, Anushey
Pubblicazione: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
di: Afroza, Halima
Pubblicazione: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
di: Sorno, Rubina Haque
Pubblicazione: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
di: Mahin, Md. Tamjidur Rahman
Pubblicazione: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
di: Fred, Namanda Rogers
Pubblicazione: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
di: Khandker, Tahia Anjum
Pubblicazione: (2024)

Synthesis and sar o acne medication
di: Naureen, Tasnia
Pubblicazione: (2024)

HPLC method development for the analysis of linagliptin
di: Mimiya, Ruhani Amrin
Pubblicazione: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
di: Paul, Pulock
Pubblicazione: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
di: Kamal, Tasnova
Pubblicazione: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023)

Trend in approval of targeted biologics in the last two decades
di: Siddika, Khadiza
Pubblicazione: (2024)

Breast cancer therapy through Liposomal drug delivery system
di: Ome, Nusrat Jahan
Pubblicazione: (2024)

Epigenetic therapy in cancer
di: Abid, Md. Shadman Ridwan
Pubblicazione: (2021)

A review on triple-negative breast cancer and its potential treatment
di: Niasa, Jannatul Ferdous
Pubblicazione: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
di: Razna, Amrin Islam
Pubblicazione: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
di: Chakraborty, Anuradha
Pubblicazione: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
di: Nahar, Kamrun
Pubblicazione: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
di: Nashrah, Zannatul
Pubblicazione: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
di: Hoque, Syeda Mehren
Pubblicazione: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
di: Parvez, Safi
Pubblicazione: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
di: Sarkar, Onusree
Pubblicazione: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
di: Hasan, Amit
Pubblicazione: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
di: Dowla, Rumana, et al.
Pubblicazione: (2022)